DocDollars

Currax Pharmaceuticals LLC

TN · United States · Reporting entity ID 100000521825

Total reported 2019–2025
$19.5M
#324 of 2,960 reporting companies — 0% of all reported industry payments
$1.39M in general payments across 57,613 records, plus $18.1M in research funding across 2,708 records.

How it breaks down

General payments $1,392,348
Research funding $18,082,319

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Currax Pharmaceuticals LLC reported $19.5M to US doctors and teaching hospitals from 2019 to 2025, ranking #324 of 2,960 reporting companies. 93% of that was research funding and 7% general payments such as consulting, speaking, food and travel. 57,613 general payment records and 2,708 research records were filed.

Common questions about Currax Pharmaceuticals LLC

How much has Currax Pharmaceuticals LLC paid US doctors?

Currax Pharmaceuticals LLC reported $19,474,668 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,392,348 in general payments, $18,082,319 in research funding.

How does Currax Pharmaceuticals LLC rank among drug and device companies?

It ranks #324 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Currax Pharmaceuticals LLC mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.